Target intelligence / Profile preview

Oocyte mitochondria (None standardized)

Target
None standardized
Molecular classification
Organelle
01

Overview

Oocyte mitochondria are subcellular organelles present in high numbers (100,000-400,000 per mature oocyte) that serve as the primary energy producers for oocyte maturation, fertilization, and early embryonic development. These organelles accumulate substantial mitochondrial DNA content during oocyte growth and are maternally inherited by the developing embryo. Mitochondrial ATP production is critical because glycolysis is suppressed during oocyte maturation and early preimplantation development, making oocytes uniquely dependent on oxidative phosphorylation. Mitochondrial dysfunction, characterized by impaired ATP synthesis and increased reactive oxygen species production, is associated with decreased oocyte quality, chromosomal segregation errors, and reduced fertility. While oocyte mitochondria are not conventional drug targets, therapeutic strategies have been proposed to enhance mitochondrial function—including antioxidant treatments and modulation of mitochondrial dynamics proteins—to improve fertility outcomes.

Other names
Mitochondria in oocytes
02

Mechanism of action

Not applicable (this is not a targetable molecular entity)

03

Biological functions

ATP (energy) production via oxidative phosphorylationSupport of oocyte maturation and meiosisProvision of energy for early embryonic development (preimplantation stage)Regulation of calcium homeostasisControl of reactive oxygen species (ROS) productionRegulation of cell death pathways (apoptosis)Epigenetic regulation through metabolite signalingMitochondrial DNA inheritance (exclusively maternal)Support of chromosome segregation during cell division
04

Disease associations

InfertilityAge-related fertility declineReproductive dysfunction (secondary to mitochondrial dysfunction rather than primary targets)
05

Safety considerations

Not applicable in the traditional sense; however, interventions affecting mitochondrial function in oocytes could impact transgenerational epigenetic inheritance and long-term offspring health
06

Interacting drugs

None
07

Biomarkers

Oocyte ATP levelsmtDNA copy numberROS levelsMitochondrial morphology and distribution patterns (used for oocyte quality assessment)

Beyond the preview

Go deeper on Oocyte mitochondria (None standardized).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oocyte mitochondria (None standardized).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call